OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Infectious Pleural Effusion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,490 reports · 69 co-occurring drugs

As of the last recalculation, Infectious Pleural Effusion appears in 1,490 FAERS reports alongside 69 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 42.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab3542.542.7
Voriconazole Injection3825.125.1
Micafungin Sodium1525.025.0
Atovaquone1424.524.6
Piperacillin And Tazobactam1819.919.9
Voriconazole4018.918.9
Tacrolimus Ointment 0.1%14918.518.5
Tacrolimus Extended-Release Capsules14918.418.4
Pyrazinamide1218.018.0
Posaconazole Delayed-Release1418.018.0
Remdesivir1616.917.0
Mycophenilic Acid2416.416.4
Tacrolimus16516.416.4
Piperacillin Sodium,Tazobactam Sodium3016.116.1
Amphotericin B1415.715.8
Meropenem3515.615.6
Piperacillin Sodium And Tazobactam Sodium2115.215.2
Valganciclovir Hydrochloride Powder,1315.015.0
Valganciclovir2015.015.0
Valganciclovir Hydrochloride2015.015.0
Cefepime Hydrochloride1614.014.0
Cefazolin913.913.9
Cefepime1413.813.8
Durvalumab1913.213.2
Posaconazole1513.013.0
Linezolid2712.912.9
Cefazolin Sodium1112.812.8
Atezolizumab3412.512.5
Mycophenolate Mofetil10311.311.3
Isoniazid1311.311.3
Mycophenolate Mofetil Hydrochloride10311.311.3
Mycophenolic Acid2511.111.1
Dexamethasone Sodium Phosphate811.111.1
Fexofenadine Hcl710.610.6
Rifampin1110.610.6
Ganciclovir79.69.6
Paclitaxel659.59.5
Paclitaxel (Aibumin-Bound)549.59.5
Ganciclovir Sodium79.39.3
Tocilizumab729.29.2
Carfilzomib189.09.0
Vancomycin368.98.9
Baricitinib68.78.7
Vancomycin Hydrochloride408.78.7
Ceftriaxone208.68.6
Ceftriaxone Sodium228.18.1
Cisplatin448.18.1
Carboplatin697.97.9
Daptomycin57.67.6
Alteplase87.57.5
Fluorouracil Cream, 0.5%397.37.3
Nivolumab497.37.3
Bendamustine Hcl87.27.2
Fluorouracil397.27.2
Pembrolizumab496.76.7
Irinotecan Hydrochloride66.56.5
Bevacizumab566.56.5
Suvorexant66.56.5
Lenvatinib156.46.4
Ipilimumab196.26.2
Gefitinib46.26.2
Etoposide316.06.0
Sofosbuvir85.75.7
Sarilumab105.35.3
Dasatinib124.54.5
Crizotinib44.44.4
Osimertinib93.93.9
Cabozantinib123.53.5
Pomalidomide202.72.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.